114 related articles for article (PubMed ID: 9571968)
1. [Effect of 5'-DFUR used concurrently in radiotherapy and immunotherapy uterine cervical cancer--pilot study. Study of 5'-DFUR for Uterine Cervical Cancer].
Hatae M; Noda K; Yajima A; Sato S; Terashima Y; Ochiai K; Sasaki H; Mizutani K; Honjo H; Yamamoto T; Ozaki M; Yamamoto K; Hasegawa K; Nishimura R; Kudo T; Kobashi Y; Yakushiji M; Sugiyama T; Hasuo Y; Onishi Y
Gan To Kagaku Ryoho; 1998 Apr; 25(5):705-11. PubMed ID: 9571968
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
Noda K; Ikeda M; Saito Y; Yajima A; Sato A; Suzuki M; Terashima Y; Ochiai K; Yoshida K; Takada M
Gan To Kagaku Ryoho; 1991 Dec; 18(15):2557-65. PubMed ID: 1660700
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer.
Nakano T; Oka K; Hanba K; Morita S
Clin Immunol Immunopathol; 1996 Apr; 79(1):79-86. PubMed ID: 8612354
[TBL] [Abstract][Full Text] [Related]
4. Clinical effect of sizofiran combined with irradiation in cervical cancer patients: a randomized controlled study. Cooperative Study Group on SPG for Gynecological Cancer.
Noda K; Takeuchi S; Yajima A; Akiya K; Kasamatsu T; Tomoda Y; Ozawa M; Sekiba K; Sugimori H; Hashimoto S
Jpn J Clin Oncol; 1992 Feb; 22(1):17-25. PubMed ID: 1573785
[TBL] [Abstract][Full Text] [Related]
5. Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer.
Yamamoto K; Noda K; Hatae M; Kudo T; Hasegawa K; Nishimura R; Honjo H; Yajima A; Sato S; Mizutani K; Yakushiji M; Terashima Y; Ochiai K; Sasaki H; Ozaki M
Oncol Rep; 2001; 8(2):273-7. PubMed ID: 11182039
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy.
Sato S; Yajima A; Sasaki H; Mizutani K; Honjo H; Yamamoto K; Ozaki M; Hasegawa K; Kudo T; Yakushiji M; Hatae M; Noda K
Oncol Rep; 2001; 8(2):239-44. PubMed ID: 11182033
[TBL] [Abstract][Full Text] [Related]
7. [Electron microscopic and immunological studies concerning the effect on the antitumor activity of sizofiran (SPG) combined with radiotherapy for cervical cancer].
Hasegawa K; Nishimura R; Kinugasa M; Okamura M; Kimura A; Ohtsu F; Takeuchi K; Mizuhira V
Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2549-61. PubMed ID: 2124607
[TBL] [Abstract][Full Text] [Related]
8. [5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
Suzuki M; Aida I; Ohwada M; Sato I; Tamura T; Kasuga Y
Gan To Kagaku Ryoho; 1995 Feb; 22(2):253-8. PubMed ID: 7857101
[TBL] [Abstract][Full Text] [Related]
9. [The study on the immunological effect of sizofilan combined with radiotherapy in patients with uterine cervical cancer].
Sekiguchi I; Suzuki M; Izumi A; Aida I; Tamada T
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2659-64. PubMed ID: 2126027
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of 5-fluorouracil (5-FU) levels and pyrimidine nucleoside phosphorylase activities in the tissues from patients with uterine cervical and ovarian cancers after oral administration of 5'-DFUR].
Noda K; Watanabe Y; Ikeda M; Takeuchi K; Hasegawa K; Kinugasa M; Sekiba K; Kobashi Y; Ohiwa T; Odagiri H
Gan To Kagaku Ryoho; 1991 Dec; 18(15):2551-5. PubMed ID: 1836128
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer].
Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060
[TBL] [Abstract][Full Text] [Related]
12. Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study.
DiSaia PJ; Bundy BN; Curry SL; Schlaerth J; Thigpen JT
Gynecol Oncol; 1987 Mar; 26(3):386-97. PubMed ID: 3549476
[TBL] [Abstract][Full Text] [Related]
13. [Improvement in the effects of radiation therapy with BRM].
Inomata T; Ogawa Y; Nishioka A; Maeda T; Seguchi H
Gan No Rinsho; 1990 Oct; 36(13):2278-85. PubMed ID: 2123503
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023
[TBL] [Abstract][Full Text] [Related]
15. Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival.
Miyazaki K; Mizutani H; Katabuchi H; Fukuma K; Fujisaki S; Okamura H
Gynecol Oncol; 1995 Mar; 56(3):412-20. PubMed ID: 7705677
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323
[TBL] [Abstract][Full Text] [Related]
17. [Combination therapy of high dose doxifluridine (5'-DFUR)+mitomycin C (MMC) for advanced or recurrent colorectal cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
Kikkawa N; Taguchi T; Sakai K; Irie K; Terasawa T; Shimoyama T; Iwanaga T; Fukuda I; Okumura S; Yasutake K
Gan To Kagaku Ryoho; 1993 Jan; 20(1):117-23. PubMed ID: 8422175
[TBL] [Abstract][Full Text] [Related]
18. [A phase I study of docetaxel (TXT) and doxifluridine (5'-DFUR) combination therapy in patients with advanced and recurrent breast cancer].
Tominaga T; Nishimura R; Aoyama H; Iwase H; Mitsuyama S; Asaga T; Kimura M;
Gan To Kagaku Ryoho; 2001 Jul; 28(7):965-72. PubMed ID: 11478146
[TBL] [Abstract][Full Text] [Related]
19. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of low-dose weekly docetaxel combined with oral 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced or metastatic breast cancer: a pilot trial].
Harada Y; Ohuchi N; Ohnuki K; Amano G; Yoshida R; Furuta A; Ikegaki H; Kijima G; Satomi S
Gan To Kagaku Ryoho; 2000 Apr; 27(4):579-84. PubMed ID: 10791000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
